BioNTech SE entered into an agreement to acquire remaining stake in InstaDeep Ltd for approximately £560 million on January 10, 2023. BioNTech will pay an upfront consideration of approximately £360 million in cash and BioNTech shares. InstaDeep shareholders will receive additional performance based future milestone payments up to approximately £200 million. Approximately 240 professionals of InstaDeep will join BioNTech. Upon closing, InstaDeep will operate as a UK-based global subsidiary of BioNTech. The transaction is subjected to regulatory approval. The transaction is expected to close in the first half of 2023. Valentina Santambrogio, Andrew Quayle, Jennifer Ross, Raghav Vohora, Diana Pysarenko, Vitalii Mainarovych, Kate Darracott, Mala Patel, Jacqueline Vallat, Isobel Thomas and Jacqueline Vallat of CMS Cameron McKenna Nabarro Olswang LLP, Jürgen Frodermann, Martin Friedberg, Rolf Hempel, Amelie Schäfer of CMS Hasche Sigle Partnerschaft von Rechtsanwälten und Steuerberatern mbB, Annabelle Bailleul-Mirabaud, Thibault Jabouley, Caroline Froger-Michon, Claire Vannini of CMS Francis Lefebvre Avocats, Bernard Mofokeng and Nico Alberts of CMS RM Partners and John O?Connor of Cms (Uae) Llp acted as legal advisors to the founders and other investors of InstaDeep. Eyad F. Latif and Mike Turner of Latham & Watkins LLP acted as legal advisor for Chimera Investments LLC.

BioNTech SE completed the acquisition of remaining stake in InstaDeep Ltd on July 31, 2023. Total revised consideration is approximately £430 million which includes cash, BioNTech shares and success-based milestone payments.